ZEOX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ZEOX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Zeo ScientifiX's annualized Net Income for the quarter that ended in Jan. 2025 was $-4.97 Mil. Zeo ScientifiX's average total tangible assets for the quarter that ended in Jan. 2025 was $1.60 Mil. Therefore, Zeo ScientifiX's annualized Return-on-Tangible-Asset for the quarter that ended in Jan. 2025 was -311.43%.
The historical rank and industry rank for Zeo ScientifiX's Return-on-Tangible-Asset or its related term are showing as below:
During the past 13 years, Zeo ScientifiX's highest Return-on-Tangible-Asset was -155.56%. The lowest was -4014.32%. And the median was -840.48%.
The historical data trend for Zeo ScientifiX's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX Annual Data | |||||||||||||||||||||
Trend | Oct15 | Oct16 | Oct17 | Oct18 | Oct19 | Oct20 | Oct21 | Oct22 | Oct23 | Oct24 | |||||||||||
Return-on-Tangible-Asset | Get a 7-Day Free Trial |
![]() |
![]() |
-1,269.09 | -780.96 | -218.76 | -155.56 | -212.66 |
Zeo ScientifiX Quarterly Data | ||||||||||||||||||||
Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | Apr24 | Jul24 | Oct24 | Jan25 | |
Return-on-Tangible-Asset | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-159.57 | -256.46 | -194.94 | -259.63 | -311.43 |
For the Biotechnology subindustry, Zeo ScientifiX's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Return-on-Tangible-Asset falls into.
Zeo ScientifiX's annualized Return-on-Tangible-Asset for the fiscal year that ended in Oct. 2024 is calculated as:
Return-on-Tangible-Asset | = | Net Income | / | ( (Total Tangible Assets | + | Total Tangible Assets) | / count ) |
(A: Oct. 2024 ) | (A: Oct. 2023 ) | (A: Oct. 2024 ) | |||||
= | Net Income | / | ( (Total Assets - Intangible Assets | + | Total Assets - Intangible Assets) | / count ) | |
(A: Oct. 2024 ) | (A: Oct. 2023 ) | (A: Oct. 2024 ) | |||||
= | -4.705 | / | ( (2.782 | + | 1.643) | / 2 ) | |
= | -4.705 | / | 2.2125 | ||||
= | -212.66 % |
Zeo ScientifiX's annualized Return-on-Tangible-Asset for the quarter that ended in Jan. 2025 is calculated as:
Return-on-Tangible-Asset | = | Net Income | / | ( (Total Tangible Assets | + | Total Tangible Assets) | / count ) |
(Q: Jan. 2025 ) | (Q: Oct. 2024 ) | (Q: Jan. 2025 ) | |||||
= | Net Income | / | ( (Total Assets - Intangible Assets | + | Total Assets - Intangible Assets) | / count ) | |
(Q: Jan. 2025 ) | (Q: Oct. 2024 ) | (Q: Jan. 2025 ) | |||||
= | -4.972 | / | ( (1.643 | + | 1.55) | / 2 ) | |
= | -4.972 | / | 1.5965 | ||||
= | -311.43 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Jan. 2025) net income data.
Zeo ScientifiX (OTCPK:ZEOX) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Thank you for viewing the detailed overview of Zeo ScientifiX's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Skycrest Holdings, Llc | 10 percent owner | 1930 HARRISON STREET, SUITE 204, HOLLYWOOD FL 33020 |
Harry L. Leider | director, officer: CEO and Director | C/O GELESIS, INC., 501 BOYLSTON STREET, SUITE 6102, BOSTON MA 02116 |
Howard Lawrence Golub | officer: Executive Vice President & CSO | 23648 SEPTEMBER SUN SQ, ASHBURN VA 20148 |
Matthew Phillip Sinnreich | officer: COO and Acting CEO | 4045 SHERIDAN AVENUE, SUITE 239, MIAMI BEACH FL 33139 |
Steven Jerry Glauser | director | 1428 BRICKELL AVENUE, SUITE 105, MIAMI FL 33131 |
Leathem S Stearn | director | 2306 BAY DRIVE, POMPANO BEACH FL 33062 |
Charles Luther Bretz | director | 58 N. CHICAGO ST, 2ND FLOOR, JOLIET IL 60432 |
Bhupendra Kumar Modi | director | 6 MARINA BOULEVARD, #63-18, THE SALE @ MARINA BAY U0 018985 |
Gurvinder Pal Singh | director | E - 128, FIRST FLOOR, GREATER KAILASH - II, NEW DELHI K7 110048 |
John F Chiste | director | |
Ryan C Likes | officer: Chief Operating Officer | 1116 MEADOWBROOK AVE., LOS ANGELES CA 90019 |
Greyt Ventures, Llc | 10 percent owner | GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180 |
Wendy Grey | 10 percent owner | GREYT VENTURES, LLC, 20533 BISCAYNE BOULEVARD, SUITE 648, AVENTURA FL 33180 |
Ian T Bothwell | 10 percent owner, officer: Chief Financial Officer | 77 530 ENFIELD LANE, BLDG D, PALM DESERT CA 92211 |
Albert Mitrani | director, officer: Chief Executive Officer | 4045 SHERIDAN AVE., SUITE 239, MIAMI BEACH FL 33140 |
From GuruFocus
By Marketwired Marketwired • 05-05-2020
By ACCESSWIRE • 06-29-2023
By PRNewswire PRNewswire • 11-09-2021
By ACCESSWIRE • 11-28-2023
By ACCESSWIRE • 07-26-2023
By ACCESSWIRE • 03-07-2024
By ACCESSWIRE ACCESSWIRE • 07-26-2022
By ACCESSWIRE • 10-01-2024
By Marketwired Marketwired • 05-27-2020
By ACCESSWIRE ACCESSWIRE • 11-22-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.